Sarcopenic Obesity in Neurodisabilities

Completed

• Conditions: Sarcopenic Obesity; Stroke; Traumatic Brain Injury; Spinal Cord Injuries; Multiple Sclerosis

• Registration Number: NCT03863379
• Lead Sponsor: Dionyssiotis, Yannis, M.D.

Brief Summary

To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-02-28
• Study First Submitted QC: 2019-03-01
• Study First Posted: 2019-03-05
• Study Start: 2019-05-02
• Primary Completion: 2021-06-15
• Study Completion: 2022-05-15
• Status Verified: 2023-01
• Last Update Submitted: 2023-01-25
• Last Update Posted: 2023-01-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Persons with

• stroke / cerebrovascular disease
• traumatic brain injury
• multiple sclerosis
• spinal cord injuries (including spinal cord lesions i.e. myelopathies etc.)

Exclusion Criteria

Persons with

• heterotopic ossifications,
• chronic administration of drugs, which promote fat increase
• chronic administration of drugs, which promote bone or muscle loss
• co-existing other diseases such as: endocrinopathies, muscular dystrophies, non-alcoholic fatty liver disease.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Fat and lean mass in neurodisabled	an average of 1 year
Frequency of sarcopenic obesity	an average of 1 year

Secondary Outcome Measures

Name	Time	Method
Body mass index correlation with fat mass and visceral fat	an average of 1 year

Trial Locations

Locations (1)

National Rehabilitation Center EKA; 🇬🇷 Ilion, Athens, Greece